Quantcast
Last updated on April 23, 2014 at 13:28 EDT

Latest Osseon Therapeutics Inc. Stories

2013-12-06 08:24:40

SANTA ROSA, Calif., Dec. 6, 2013 /PRNewswire/ -- Osseon Therapeutics, Inc. is pleased to announce that Gary Hogman has joined the company as the latest member of its Sales Management team. Mr. Hogman's expertise in the Spine and Vertebral Compression Fracture arena as well as his location in Dallas, TX, is an asset to the Osseon sales and marketing team's expanding independent distributor network. Gary brings over fifteen years of experience in Orthopedic/Spine medical device sales,...

2013-06-14 08:25:24

SANTA ROSA, Calif., June 14, 2013 /PRNewswire/ -- Osseon(®) announces the release of the Osseoflex(®) CD-H hydraulic cement delivery system. This latest addition to the Osseon product line is designed for delivery of medium to high viscosity bone cement during the treatment of vertebral compression fractures (VCF). The Osseoflex(®) CD-H hydraulic cement delivery system complements Osseon's family of steerable vertebral augmentation devices. The Osseoflex(®) CD-H...

2013-04-16 04:21:53

SANTA ROSA, Calif., April 16, 2013 PRNewswire/ -- Osseon(®) Therapeutics, Inc. announced that Dr. G. Brooks Brennan, an Interventional Radiologist with Radisphere National Radiology Group, recently performed the first steerable Balloon Osseoplasty in Ohio, at Lima Memorial Hospital. His patient presented with a vertebral compression fracture brought on by osteoporosis, a painful prognosis that negatively affects ones quality of life. Dr. Brennan utilized a new technology from Osseon...

2013-01-31 08:31:05

SANTA ROSA, Calif., Jan. 31, 2013 /PRNewswire/ -- Osseon(®) Therapeutics, Inc. announced today that it has raised a $14 million round of equity financing led by a private investor. The proceeds will allow Osseon to expand its VCF device product line and continue to provide innovative devices for the treatment of vertebral compression fractures. The new series of financing was completed in conjunction with existing investors who support Osseon's vision of becoming a preeminent spine...

2012-10-24 15:25:36

SANTA ROSA, Calif., Oct. 24, 2012 /PRNewswire/ -- Osseon(®) Therapeutics, Inc. announced today the commercial release in the U.S. of its newest product, the Osseoflex(®) SB steerable inflatable bone tamp. After successful launch and distribution in Europe, the Osseoflex SB has received FDA clearance for sale in the U.S. Osseon will be displaying its portfolio of steerable vertebral augmentation products at the NASS (North American Spine Society) tradeshow in Dallas, TX , Booth...

2012-10-15 11:27:13

SANTA ROSA, Calif., Oct. 15, 2012 /PRNewswire/ -- Osseon Therapeutics, Inc. is gearing up for growth as European sales now account for over 40% of sales since new product introductions in Europe. Osseon's newest product, the Osseoflex(®) SB, represents the first technological advance in vertebral augmentation devices in years. The Osseoflex SB steerable bone tamp, introduced to the European marketplace in Q2 2012, has driven the company's revenue. Distribution has expanded to 6...

2012-09-11 02:28:51

SANTA ROSA, Calif., Sept. 11, 2012 /PRNewswire/ -- Osseon announces the release of Osseoflex(®) SN+ (steerable needle) for the treatment of vertebral compression fractures (VCF). Osseoflex SN+ is the latest addition to Osseon's family of vertebral augmentation medical devices. Osseoflex SN+ is steerable and can be used for either bipedicular or unipedicular access, cavity creation, and vertebral augmentation within the vertebral body. Osseoflex SN+ shares all of the features and benefits...

2012-08-29 02:25:58

SANTA ROSA, Calif., Aug. 29, 2012 /PRNewswire/ -- Osseon(®) Therapeutics, Inc. announced today that it has named Mr. Ron Clough as Chief Operating Officer. Mr. Clough has extensive experience with several companies that develop and market medical devices for the treatment of spinal disease and deformities. Most recently, he served as VP of Operations at Theken Spine and was a key executive in the acquisition and integration of Theken Spine into Integra LifeSciences, an...

2012-02-27 03:00:00

SANTA ROSA, Calif., Feb. 27, 2012 /PRNewswire/ -- Osseon(®) Therapeutics, Inc. announced today that the company has entered into an International Distribution Agreement with Aesculap AG to distribute its vertebral compression fracture (VCF) treatment devices, including its new CE-Mark approved device - Osseoflex(®) SB (steerable balloon) in select regions of Europe and Asia. Aesculap is a division of B. Braun Melsungen, a large medical and pharmaceutical company headquartered in...

2011-09-01 11:30:00

SANTA ROSA, Calif., Sept. 1, 2011 /PRNewswire/ -- Today, Osseon® Therapeutics, Inc. launched the Osseoflex®SN (steerable needle). Osseoflex SN is the newest in Osseon's suite of minimally invasive products for treatment of spinal compression fractures. (Photo: http://photos.prnewswire.com/prnh/20110901/SF61461) The Osseoflex SN allows direct unipedicular access to the entire vertebral body. The Osseoplasty(TM) procedure offers unparalleled flexibility...